1. Home
  2. APA vs RDY Comparison

APA vs RDY Comparison

Compare APA & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo APA Corporation

APA

APA Corporation

HOLD

Current Price

$32.97

Market Cap

12.9B

Sector

Energy

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.88

Market Cap

11.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APA
RDY
Founded
1954
1984
Country
United States
India
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
11.9B
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
APA
RDY
Price
$32.97
$14.88
Analyst Decision
Hold
Strong Buy
Analyst Count
23
1
Target Price
$31.96
$16.90
AVG Volume (30 Days)
5.4M
2.1M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
2.48%
0.52%
EPS Growth
75.77
N/A
EPS
1.26
N/A
Revenue
N/A
N/A
Revenue This Year
$3.86
$7.72
Revenue Next Year
N/A
$3.50
P/E Ratio
$26.18
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$17.87
$12.19
52 Week High
$45.66
$15.67

Technical Indicators

Market Signals
Indicator
APA
RDY
Relative Strength Index (RSI) 36.05 65.97
Support Level $22.73 $13.80
Resistance Level $38.75 $14.87
Average True Range (ATR) 1.06 0.31
MACD -0.24 0.21
Stochastic Oscillator 6.68 67.76

Price Performance

Historical Comparison
APA
RDY

About APA APA Corporation

APA Corp is an independent exploration and production company. It develops and produces crude oil, natural gas, and natural gas liquids. The company's business has oil and gas operations in four segments: Egypt, the North Sea, Suriname, and the U.S. The company generates the majority of its revenue from the U.S. reporting segment. The company also has exploration interests in Uruguay, Alaska, and other international locations.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: